"10.1371_journal.pone.0151503","plos one","2016-03-18T00:00:00Z","Marcia C de Oliveira Otto; Ashkan Afshin; Renata Micha; Shahab Khatibzadeh; Saman Fahimi; Gitanjali Singh; Goodarz Danaei; Rosely Sichieri; Carlos A Monteiro; Maria L C Louzada; Majid Ezzati; Dariush Mozaffarian; Global Burden of Diseases, Injuries, and Risk Factors Metabolic Risk Factors of Chronic Diseases Expert Group and Nutrition and Chronic Diseases Expert Group (NutriCoDE)","Division of Epidemiology, Human Genetics and Environmental Sciences, the University of Texas Health Science Center, School of Public Health, Houston, Texas, United States of America; Friedman School of Nutrition Science & Policy, Tufts University, Boston, Massachusetts, United States of America; Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Food Science and Human Nutrition, Agricultural University of Athens, Athens, Greece; Departament of Epidemiology, University of the State of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil; Department of Nutrition, School of Public Health, University of SÃ£o Paulo, Sao Paulo, Sao Paulo, Brazil; Faculty of Medicine, School of Public Health, Imperial College of London, London, United Kingdom","Conceived and designed the experiments: MO AA DM GD ME GS RM SF. Analyzed the data: MO. Wrote the paper: MO. Revised and provided comments to the manuscript: AA RM SK SF GS RS CM ML ME DM.","Dr. Otto was supported by unrestricted educational grants from Bunge LLC and from Swiss Re. Dr. Mozaffarian reports ad hoc honoraria or consulting from Bunge, Haas Avocado Board, Nutrition Impact, Amarin, Astra Zeneca, Boston Heart Diagnostics, GOED, and Life Sciences Research Organization; and scientific advisory boards, Unilever North America and Elysium Health. Harvard University holds a patent, listing Dr. Mozaffarian as one of three co-inventors, for use of trans-palmitoleic acid to prevent and treat insulin resistance, type 2 diabetes, and related conditions. The other authors report no conflicts. There are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","03","Marcia C de Oliveira Otto","MCDOO",13,TRUE,8,NA,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
